Skip to main content

Table 1 Baseline Characteristics of Seroconverter HBM in the MACS Data

From: Methods of competing risks flexible parametric modeling for estimation of the risk of the first disease among HIV infected men

Variables*patientsAIDS
(N = 267)
Non-AIDS
(N = 156)
Death
(N = 25)
MACS recruitmentN = 674   
1984–85 & 1987–90581(86.20)266(99.63)132(84.62)23(92.00)
2001–3 & 201093(13.80)1(0.37)24(15.38)2(8.00)
Age at diagnosisN = 667   
<40473(70.91)205(77.36)94(60.26)14(58.33)
40194(29.09)60(22.64)62(39.74)10(41.67)
Baseline CD4, per μlN = 629   
< 35051(8.11)22(8.84)9(6.04)0(0.00)
350–500102(16.22)47(18.88)16(10.74)6(31.58)
500476(75.68)180(72.29)124(83.22)13(68.42)
Baseline CD8, per μlN = 629   
< 50091(14.47)45(18.07)17(11.41)4(21.05)
500–1000337(53.58)129(51.81)79(53.02)12(63.16)
1000201(31.96)75(30.12)53(35.57)3(15.79)
Baseline WBC, per μlN = 663   
< 5000191(28.81)78(29.43)39(25.32)10(43.48)
5000472(71.19)187(70.57)115(74.68)13(56.52)
Baseline RBC, × 105, per μlN = 667   
<4.590(13.49)25(9.43)31(19.87)1(4.17)
4.5577(86.51)240(90.57)125(80.13)23(95.83)
Baseline platelets, × 103, per μlN = 660   
< 15040(6.06)10(3.77)9(5.92)6(26.09)
150–250347(52.58)127(47.92)90(59.21)8(34.78)
250273(41.36)128(48.30)53(34.87)9(39.13)
  1. *Differences between the number of patients and the sum of the AIDS, Non-AIDS and Death columns indicate the number of censored patients